User:Catherine Koenigsknecht/Notebook/Experimental Biological Chemistry/2013/02/27: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(2 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
| colspan="2"| | | colspan="2"| | ||
<!-- ##### DO NOT edit above this line unless you know what you are doing. ##### --> | <!-- ##### DO NOT edit above this line unless you know what you are doing. ##### --> | ||
Line 15: | Line 13: | ||
==Description== | ==Description== | ||
# | *Procedure from yesterday was continued with the same concentrations. Yesterday two trials were completed. The third was completed today. | ||
**The following concentrations were used. | |||
{| {{table}} | |||
| align="center" style="background:#f0f0f0;"|'''Concentration [Ado] (uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''Velocity (nm/sec)''' | |||
| align="center" style="background:#f0f0f0;"|'''1/[Ado] (1/uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''1/velocity (sec/nm)''' | |||
| align="center" style="background:#f0f0f0;"|'''''' | |||
| align="center" style="background:#f0f0f0;"|'''(-1)/Km''' | |||
| align="center" style="background:#f0f0f0;"|'''-0.022385428''' | |||
|- | |||
| 10.52||3.70166E-05||0.095057034||27014.92537||||Km||44.67191792 | |||
|- | |||
| 12.34||5.13812E-05||0.081037277||19462.36559||||1/Vmax||2662.131337 | |||
|- | |||
| 14.93||6.0221E-05||0.066979236||16605.50459||||Vmax||0.000375639 | |||
|- | |||
| 18.87||7.45856E-05||0.052994171||13407.40741|||||| | |||
|- | |||
| 25.64||8.67403E-05||0.03900156||11528.66242|||||| | |||
|- | |||
| 40||9.94475E-05||0.025||10055.55556|||||| | |||
|- | |||
| | |||
|} | |||
*10mM Quercetin stock was prepared. | |||
*Cuvettes with the following solutions were prepared and analyzed. | |||
**Today, we only had time to complete the first two. | |||
{| {{table}} | |||
| align="center" style="background:#f0f0f0;"|'''[ADA Stock Solution] (U/mL)''' | |||
| align="center" style="background:#f0f0f0;"|'''Volume ADA Stock Solution Added (mL)''' | |||
| align="center" style="background:#f0f0f0;"|'''Final [ADA] (U/mL)''' | |||
| align="center" style="background:#f0f0f0;"|'''[Adenosine Stock Solution] (uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''Volume Adenosine Stock Solution Added (mL)''' | |||
| align="center" style="background:#f0f0f0;"|'''Final [Adenosine] (uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''Volume 0.05 M Phosphate Buffer Added (mL)''' | |||
| align="center" style="background:#f0f0f0;"|'''Volume Inhibitor Stock solution added''' | |||
| align="center" style="background:#f0f0f0;"|'''[Inhibitor Stock Solution] (uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''[Final Inhibitor] (uM)''' | |||
| align="center" style="background:#f0f0f0;"|'''Total Volume (mL)''' | |||
|- | |||
| 0.5||0.02||0.00333||52.63157895||0.6||10.52631579||1.78||0.6||65||13||3 | |||
|- | |||
| 0.5||0.02||0.00333||61.72839506||0.6||12.34567901||1.78||0.6||65||13||3 | |||
|- | |||
| 0.5||0.02||0.00333||74.62686567||0.6||14.92537313||1.78||0.6||65||13||3 | |||
|- | |||
| 0.5||0.02||0.00333||94.33962264||0.6||18.86792453||1.78||0.6||65||13||3 | |||
|- | |||
| 0.5||0.02||0.00333||128.2051282||0.6||25.64102564||1.78||0.6||65||13||3 | |||
|- | |||
| 0.5||0.02||0.00333||200||0.6||40||1.78||0.6||65||13||3 | |||
|- | |||
| | |||
|} | |||
==Data== | ==Data== | ||
* | *The following chart was prepared from the UV/Vis absorbance data for the assay solutions without Quercetin. | ||
[[Image:3_5data.JPG]] | |||
*Data for the two Quercetin trials completed today will be uploaded next week, along with the rest, once they are complete. | |||
==Notes== | ==Notes== |
Revision as of 18:54, 1 April 2013
Biomaterials Design Lab | <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Objective
Description
Data
NotesThis area is for any observations or conclusions that you would like to note.
|